Ironwood gets U.S. rights to AZ's Zurampic

AstraZeneca plc (LSE:AZN; NYSE:AZN) granted Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) exclusive, U.S. rights to Zurampic lesinurad, which

Read the full 164 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE